PlainRecalls
FDA Drug Moderate Class II Terminated

Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5

Reported: September 23, 2015 Initiated: August 17, 2015 #D-1814-2015

Product Description

Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5

Reason for Recall

Failed Stability Specifications: product may not meet specification limit for assay test.

Details

Recalling Firm
Apotex Inc.
Units Affected
117,644 Bottles
Distribution
Nationwide and Puerto Rico
Location
Toronto

Frequently Asked Questions

What product was recalled?
Cevimeline Hydrochloride Capsules, 30 mg a) 100 count bottle, and b) 500 count bottle, Rx Only, Manufactured by: Apotex Research Pvt., Ltd., Bangalore, India, Manufactured for: Apotex Corp, Westin, FL, a) NDC 60505-3145-1, b) NDC 60505-3145-5. Recalled by Apotex Inc.. Units affected: 117,644 Bottles.
Why was this product recalled?
Failed Stability Specifications: product may not meet specification limit for assay test.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 23, 2015. Severity: Moderate. Recall number: D-1814-2015.